Press release
Exotic Naturals to work with Shanghai SINCH Pharmaceuticals Tech. Co., Ltd
For immediate releaseMumbai, India, December 27, 2011:
Exotic Naturals, suppliers of a wide range of quality Phytochemicals & Herbal extracts announced today that it has entered into a business agreement with M/S Shanghai Sinch Pharmaceuticals Tech. Co. Ltd., a Shanghai based quality API distributing company to market Ipecacuanha extract 0.2%, 2% and 8% in China and surrounding regions. Ipecacuanha is used as an expectorant. At higher doses it is a powerful emetic. Ipecac extract is clinically tested and safe to be used in cough syrup. Extracted from non genetically modified plant source, Exotic Naturals delivers on its commitment to give not less than 2% total alkaloid by maintaining a stringent quality control at each stage of manufacturing using the Pharmacopoeial method.
Shanghai SINCH Pharmaceuticals Tech. Co., Ltd (hereinafter called “SINCH Pharmaceuticals”) is a leading pharmaceutical company specialized in the field of medicine research & development. Since its establishment in 2006, SINCH Pharmaceuticals has been focusing on developing high-quality chemical compound synthesis, herbal and natural medicines for senile and chronic diseases treatment.
SINCH Pharmaceuticals possesses a strong R&D team .The company is managed by a group of experts who have enormous work experience in first-rank multi-national pharmaceutical enterprises. Located in Wujiaochang High-tech Industry Park, a region housing renowned universities of Shanghai allows SINCH Pharmaceuticals to build a stable cooperation relationship in drug research and development with many neighboring chemical institutes.
The new partnership will initially promote Exotic’s Ipecac extract in China & Hong Kong and extend to other Indian origin herbal extract like Curcumin, Piperine, Garcinia, Boswellia, Glycyrrhiza extracts and Thiocolchicoside according to officials of both the organizations.
“We are extremely pleased & enthusiastic about our association with Sinch Pharma,” said Dr Diwakar Jha, Head – International Business, Exotic Naturals. Both the companies are research oriented and have a common interest in dealing with innovative and newer ingredients for use in health care, hence the partnership will go a long way feel Dr. Diwakar Jha and Dr Wang Zheng, Director, Sinch Pharma.
About Exotic Naturals
Established in 1994, Exotic Naturals is an ISO 9001:2008, Organic and Kosher Certified Company. Serving the needs of the Nutraceutical, Pharmaceutical and Cosmetics, Food & Agriculture industry supplying quality Phytochemicals, APIs &Herbal extracts, crop protectants, Bio-fertilizers and plant growth promoting agents. For more news log onto www.exoticnatural.com
203, Morya Landmark 1, Off Link Road, Andheri West, Mumbai 400053, India
This release was published on openPR.
Permanent link to this press release:
Copy
Please set a link in the press area of your homepage to this press release on openPR. openPR disclaims liability for any content contained in this release.
You can edit or delete your press release Exotic Naturals to work with Shanghai SINCH Pharmaceuticals Tech. Co., Ltd here
News-ID: 205525 • Views: …
More Releases for Pharma
Miglitol Market Size, Share and Forecast By Key Players-Weiao Pharma, Zhejiang M …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Miglitol market is anticipated to grow at a compound annual growth rate (CAGR) of 11.49% between 2024 and 2031. The market is expected to grow to USD 22.32 Billion by 2024. The valuation is expected to reach USD 47.79 Billion by 2031.
The Miglitol market is experiencing significant growth due to the rising prevalence of diabetes and the increasing awareness of the…
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031.
The Dacarbazine market is projected to witness significant growth in the coming years, driven by increasing…
Dacarbazine Market Size, Share and Forecast By Key Players-Lingnan Pharma, Ruiyi …
𝐔𝐒𝐀, 𝐍𝐞𝐰 𝐉𝐞𝐫𝐬𝐞𝐲- According to the MRI Team's Market Research Intellect, the global Dacarbazine market is anticipated to grow at a compound annual growth rate (CAGR) of 14.63% between 2024 and 2031. The market is expected to grow to USD 25.32 Billion by 2024. The valuation is expected to reach USD 65.84 Billion by 2031.
The dacarbazine market is experiencing steady growth, driven by the rising incidence of cancer globally. As…
Epilepsy Pipeline Assessment 2024: Therapies, Clinical Trials, and Market Insigh …
(Las Vegas, Nevada, United States) As per DelveInsight's assessment, globally, Epilepsy pipeline constitutes 75+ key companies continuously working towards developing 90+ Epilepsy treatment therapies, analysis of Clinical Trials, Therapies, Mechanism of Action, Route of Administration, and Developments analyzes DelveInsight.
The Epilepsy Pipeline report embraces in-depth commercial and clinical assessment of the pipeline products from the pre-clinical developmental phase to the marketed phase. The report also covers a detailed description of the…
Global Indomethacin Market Seeking Excellent Growth by 2028 | Ratiopharm, Merck, …
"IBI has published a report entitled Global Indomethacin Market Research Report which provides comprehensive data on emerging trends, market drivers, growth opportunities, and barriers that could change the dynamics of the industry market. It provides an in-depth analysis of market segments which includes the product, application, and competitor analysis.
Click Here To Order A Sample Copy Of Indomethacin Global Market Report : https://www.infinitybusinessinsights.com/request_sample.php?id=380382
The Indomethacin Global Market Research Report provides close monitoring…
Roxatidine Market 2020: Top Companies Analysis To Grow Healthcare Business by 20 …
Business Industry Reports Research has recently announced a report on Global Roxatidine Market based on the Category Industry. The Roxatidine Market report emphasizes various key aspects, which include growth drivers, restraints, opportunities and recent market trends for the forecast period 2020-2024.
Global Roxatidine Market overview:
Business Industry Reports Analyst covers the Major Players data, including: shipment, revenue, gross profit, interview record, business distribution etc., these data help the consumer know about the…